|
Real-time Estimate
Cboe BZX
01:43:18 04/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 34.54 USD | -0.07% |
|
-6.82% | -2.70% |
| 03/09 | Cogent Biosciences Enters Commercial Supply Agreement With Hovione FarmaCiencia | MT |
| 01/09 | Cogent Biosciences Insider Sold Shares Worth $1,689,493, According to a Recent SEC Filing | MT |
| Market Cap | 6B 5.18B 4.88B 4.44B 8.3B 567B 8.37B 57.73B 22.41B 290B 22.53B 22.04B 952B | P/E 2026 * |
-15.3x | P/E 2027 * | -33x |
|---|---|---|---|---|---|
| Enterprise Value | 5.87B 5.06B 4.77B 4.35B 8.13B 555B 8.19B 56.48B 21.92B 284B 22.04B 21.56B 931B | EV / Sales 2026 * |
980x | EV / Sales 2027 * | 20.1x |
| Free-Float |
99.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| COGT | Delayed | |
CBOE
| COGT | Real-time |
Last Transcript : Cogent Biosciences, Inc.
| 1 day | -0.19% | ||
| 1 week | -6.82% | ||
| Current month | -1.26% | ||
| 1 month | -11.07% | ||
| 3 months | +7.13% | ||
| 6 months | -7.20% | ||
| Current year | -2.70% |
| 1 week | 34.01 |  | 36.84 |
| 1 month | 34.01 | | 43.39 |
| Current year | 30.87 | | 43.39 |
| 1 year | 11.6 | | 43.73 |
| 3 years | 3.67 | | 43.73 |
| 5 years | 3.67 | | 43.73 |
| 10 years | 3.67 | | 43.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Robbins
CEO | Chief Executive Officer | 50 | 23/10/2020 |
John Green
DFI | Director of Finance/CFO | 45 | 01/06/2018 |
John Robinson
CTO | Chief Tech/Sci/R&D Officer | 52 | 06/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Karen Ferrante
BRD | Director/Board Member | 68 | 01/02/2018 |
Arlene Morris
BRD | Director/Board Member | 74 | 26/07/2019 |
Matthew Ros
BRD | Director/Board Member | 59 | 26/07/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 27/8/26 | Exercice | Director | 136,530 | 0.0799% | ||
| 1/7/26 | Free | Director | 627 | 0.0004% | ||
| 9/6/26 | Free | Director | 17,901 | 0.0105% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.07% | -6.82% | +164.22% | +170.00% | 6B | |
| +1.03% | -2.05% | +39.28% | +94.60% | 68.87B | |
| +1.31% | +0.55% | +49.48% | +92.12% | 65.29B | |
| -0.08% | +3.98% | -12.04% | +378.65% | 27.65B | |
| +2.97% | -0.10% | +41.86% | +14.84% | 25.77B | |
| -1.07% | -7.90% | +2.17% | -15.90% | 26.08B | |
| +1.01% | +1.38% | +26.48% | -17.50% | 20.14B | |
| +3.45% | -14.83% | +225.22% | +389.50% | 17.03B | |
| +0.77% | -4.55% | -0.36% | +549.41% | 15.03B | |
| +1.38% | +7.15% | +60.20% | +165.87% | 14.5B | |
| Average | +1.01% | -2.98% | +59.65% | +182.16% | 28.64B | |
| Weighted average by Cap. | +1.06% | -2.20% | +45.25% | +142.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.99M 5.17M 4.87M 4.43M 8.29M 566M 8.35M 57.62M 22.36M 289M 22.49M 22M 950M | 293M 253M 238M 217M 405M 27.66B 408M 2.82B 1.09B 14.14B 1.1B 1.08B 46.45B |
| Net income | -399M -344M -324M -295M -552M -37.69B -556M -3.84B -1.49B -19.27B -1.5B -1.47B -63.29B | -202M -174M -164M -149M -279M -19.04B -281M -1.94B -753M -9.73B -757M -740M -31.97B |
| Net Debt | -130M -112M -105M -96M -179M -12.25B -181M -1.25B -484M -6.26B -487M -476M -20.57B | -126M -109M -102M -93.37M -175M -11.91B -176M -1.21B -471M -6.09B -474M -463M -20.01B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | USD 34.60 | +0.09% | 142,919 |
| 02/09/26 | USD 34.57 | -0.32% | 1,181,784 |
| 01/09/26 | USD 34.68 | -0.91% | 1,480,641 |
| 31/08/26 | USD 35.00 | +0.95% | 1,849,678 |
| 28/08/26 | USD 34.67 | -6.52% | 1,771,221 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COGT Stock
Select your edition
All financial news and data tailored to specific country editions
